Metraipolis › archive › dc_5abc7bffdc80
DNA methyltransferase inhibition is a therapeutic vulnerability in VHL-deficient renal cell carcinoma cells — Europe PMC PMID:41792232
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41792232
- DOI
- 10.1038/s12276-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T01:10:43.627Z
- SHA-256 of the archived text
abcd086d74ce33d0916613e22cac86fa946878eaf6a58d26e0211075441d7033- Stable URL of this page
https://metraipolis.com/documento/dc_5abc7bffdc80
How to cite
DNA methyltransferase inhibition is a therapeutic vulnerability in VHL-deficient renal cell carcinoma cells — Europe PMC PMID:41792232 — Europe PMC (en), https://europepmc.org/article/MED/41792232 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5abc7bffdc80 (Metraipolis archive dc_5abc7bffdc80, sha256 abcd086d74ce33d0916613e22cac86fa946878eaf6a58d26e0211075441d7033)
BibTeX
@misc{dc5abc7bffdc80,
title = {DNA methyltransferase inhibition is a therapeutic vulnerability in VHL-deficient renal cell carcinoma cells — Europe PMC PMID:41792232},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41792232},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5abc7bffdc80; sha256 abcd086d74ce33d0916613e22cac86fa946878eaf6a58d26e0211075441d7033},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41792232. Agents can read the archived copy with the MCP tool read_document.